Partial LXR agonist reduces atherosclerosis in ApoE-deficient mice without inducing liver steatosis and hypertriglyceridemia

被引：0

作者：

Kratzer, Adelheid ^{[1
,6
]}

Buchebner, Marlene ^{[1
]}

Becker, Tatjana M. ^{[1
]}

Pfeifer, Thomas ^{[1
]}

Uray, Georg ^{[7
]}

Ebner, Birgit ^{[2
]}

Rathke, Nora ^{[1
]}

Ahammer, Helmut ^{[3
]}

Trauner, Michael ^{[4
]}

Hoefler, Gerald ^{[5
]}

Levak-Frank, Sanja ^{[1
]}

Levi, Moshe ^{[6
]}

Kostner, Gerhard M. ^{[1
]}

Kratky, Dagmar ^{[1
]}

机构：

[1] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria

[2] Med Univ Graz, Med Res Ctr, Graz, Austria

[3] Med Univ Graz, Inst Biophys, Graz, Austria

[4] Med Univ Graz, Div Gastroenterol & Hepatol, Graz, Austria

[5] Med Univ Graz, Inst Pathol, Graz, Austria

[6] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA

[7] Karl Franzens Univ Graz, Inst Chem, Graz, Austria

来源：

FASEB JOURNAL | 2008年 / 22卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：1

共 50 条

[31] Empagliflozin Suppresses the Progression of Atherosclerosis in Diabetic apoE-Deficient Mice
Murakami, Saiko
Matsumura, Takeshi
Senokuchi, Takafumi
Ishii, Norio
Fukuda, Kazuki
Nishida, Shuhei
Kondo, Tatsuya
Araki, Eiichi
DIABETES, 2017, 66 : A51 - A51
[32] Genetic background determines the extent of atherosclerosis in ApoE-deficient mice
Dansky, HM
Charlton, SA
Sikes, JL
Heath, SC
Simantov, R
Levin, LF
Shu, P
Moore, KJ
Breslow, JL
Smith, JD
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) : 1960 - 1968
[33] Fucus vesiculosus extracts in the prevention of atherosclerosis in apoE-deficient mice
Zaragoza, M. Cleofe
Saiz, M. Puy
Simonetti, P.
Gardana, C.
Lerat, Y.
Inisan, C.
Rousseau, I.
Besnard, M.
Mitjavila, M. Teresa
FREE RADICAL RESEARCH, 2007, 41 : S60 - S60
[34] Deficiency in iNOS results in reduced atherosclerosis in ApoE-deficient mice
Detmers, PA
Mudgett, J
Hernandez, M
Hassing, H
Burton, C
Mundt, S
Chun, S
Sparrow, C
Chao, YS
Rader, DJ
Wright, SD
Pure, E
FASEB JOURNAL, 1999, 13 (05): : A659 - A659
[35] Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice
Yoshikawa, T
Shimano, H
Chen, Z
Ishibashi, S
Yamada, N
HORMONE AND METABOLIC RESEARCH, 2001, 33 (08) : 472 - 479
[36] Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator
Miao, B
Zondlo, S
Gibbs, S
Cromley, D
Hosagrahara, VP
Kirchgessner, TG
Billheimer, J
Mukherjee, R
JOURNAL OF LIPID RESEARCH, 2004, 45 (08) : 1410 - 1417
[37] Iron-deficient diet reduces atherosclerotic lesions in ApoE-deficient mice
Lee, TS
Shiao, MS
Pan, CC
Chau, LY
CIRCULATION, 1999, 99 (09) : 1222 - 1229
[38] Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice
Shan Zhen
Yao Chen
Li Zi-lun
Teng Yuan
Li Wen
Wang Jin-song
Ye Cai-sheng
Chang Guang-qi
Huang Xue-ling
Li Xiao-xi
Wang Wen-jian
Wang Shen-ming
CHINESE MEDICAL JOURNAL, 2013, 126 (03) : 515 - 520
[39] Modulation of atherosclerosis in ApoE-deficient mice by gp130 signalling
McLeod, Louise E.
Jones, Gareth W.
Najdovska, Meri
Jenkins, Brendan J.
CYTOKINE, 2014, 70 (01) : 58 - 59
[40] Role of interleukin-12 in development of atherosclerosis in apoe-deficient mice
Chau, LY
Lee, TS
Yen, HC
Pan, CC
ATHEROSCLEROSIS, 1998, 136 : S39 - S39

← 1 2 3 4 5 →